Skip to main content

Table 3 Clinical data of 5 cases diagnosed with Malassezia otitis with and without neutrophils

From: Pilot study of dogs with suppurative and non-suppurative Malassezia otitis: A case series

  Breed Age (years) Sex Type of otitis Duration of otitis Previous treatments Therapy at presentation
Case 1 Labrador Retriever 3.1 FS Bilateral
SMO
3 months Topical Aurizon®
Topical Osurnia®
Topical acetylcysteine
Topical magistral solution containing enrofloxacin
Prednisolone 0.5mg/kg q48h for 5 weeks
No topicals treatments for one week
Case 2 Rottweiler 4.3 M Unilateral SMO 1 year Ear flush Prednisolone 0.25 mg/kg q48h for 6 months
Ketoconazole 10 mg/kg q24h for 6 weeks
Case 3 Labrador Retriever 10.5 FS Bilateral
SMO
5 years Osurnia® and SurosolveTM None for 4 weeks
Case 4 Cross Breed 2.9 M Bilateral: MO on the left ear and SMO on the right ear 2 years Surolan®
Easotic®
Ear flush
Meloxicam oral
No topical treatments for two weeks
Case 5 Labrador Retriever 4.9 M Unilateral: MO 14 months Marbodex®
Marbofloxacin PO
Surolan®
Ketoconazole 12 mg/kg PO q48h for several months
No topical treatments for several months
  1. Ingredients of medication: Aurizon® (Clotrimazole, Dexamethasone, Marbofloxacin), Acetylcysteine (Lysomucil 10%; Zambon S.A., Brussels, Belgium), SurosolveTM (tromethamine-ethylenediaminetetraacetic acid (Tris-EDTA), chloroxylenol, salicylic acid); Marbodex® (marbofloxacin, clotrimazole, dexamethasone), Osurnia® (florfenicol, terbinafine and betamethasone.); Easotic® (hydrocortisone aceponate, miconazole and gentamicin); polymyxin, prednisolone and miconazole (Surolan®; Janssen Pharmaceutica NV, Beerse, Belgium)
  2. Abbreviations: FS Female Spayed, MO Malassezia otitis, M Male, PO Per os SMO Suppurative Malassezia Otitis